| Primary |
| Cardiac Failure |
25.0% |
| Cardiac Failure Chronic |
20.0% |
| Percutaneous Coronary Intervention |
10.0% |
| Anaemia |
5.0% |
| Blood Pressure Abnormal |
5.0% |
| Chronic Myeloid Leukaemia |
5.0% |
| Fluid Retention |
5.0% |
| Gastric Ulcer Prophylaxis |
5.0% |
| Hyperaldosteronism |
5.0% |
| Insomnia |
5.0% |
| Myocardial Infarction |
5.0% |
| Pleural Effusion |
5.0% |
|
| Blood Pressure Decreased |
5.0% |
| Breast Swelling |
5.0% |
| Colitis Microscopic |
5.0% |
| Dizziness Postural |
5.0% |
| Haemoglobin Decreased |
5.0% |
| Hyperammonaemia |
5.0% |
| Hypotension |
5.0% |
| International Normalised Ratio Abnormal |
5.0% |
| International Normalised Ratio Decreased |
5.0% |
| Interstitial Lung Disease |
5.0% |
| Leukoplakia Oral |
5.0% |
| Liver Disorder |
5.0% |
| Mastitis |
5.0% |
| Multi-organ Failure |
5.0% |
| Mycoplasma Infection |
5.0% |
| Nipple Pain |
5.0% |
| Peripheral Arterial Occlusive Disease |
5.0% |
| Seborrhoeic Keratosis |
5.0% |
| Syncope |
5.0% |
| Thrombocytopenia |
5.0% |
|
| Secondary |
| Product Used For Unknown Indication |
48.8% |
| Cardiac Failure |
11.5% |
| Chronic Hepatitis C |
6.5% |
| Prophylaxis |
6.5% |
| Adverse Event |
2.4% |
| Hypertension |
2.4% |
| Fluid Retention |
2.2% |
| Hypoalbuminaemia |
2.2% |
| Adenocarcinoma Pancreas |
1.9% |
| Cardiac Failure Congestive |
1.9% |
| Constipation |
1.7% |
| Infection |
1.7% |
| Insomnia |
1.7% |
| Pyrexia |
1.7% |
| Atrial Fibrillation |
1.4% |
| Cardiac Failure Chronic |
1.4% |
| Castleman's Disease |
1.2% |
| Diabetes Mellitus |
1.2% |
| Acute Myocardial Infarction |
1.0% |
| Anaemia |
1.0% |
|
| Drug Reaction With Eosinophilia And Systemic Symptoms |
15.0% |
| Thirst |
10.0% |
| Hypernatraemia |
7.5% |
| Urinary Tract Infection |
7.5% |
| Dehydration |
5.0% |
| International Normalised Ratio Abnormal |
5.0% |
| Interstitial Lung Disease |
5.0% |
| Malaise |
5.0% |
| Renal Disorder |
5.0% |
| Thrombocytopenia |
5.0% |
| Toxic Epidermal Necrolysis |
5.0% |
| Transaminases Increased |
5.0% |
| Blood Pressure Decreased |
2.5% |
| Hypotension |
2.5% |
| Influenza |
2.5% |
| Nausea |
2.5% |
| Oesophageal Varices Haemorrhage |
2.5% |
| Pancytopenia |
2.5% |
| Pneumonia |
2.5% |
| Pneumonia Aspiration |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
18.6% |
| Cardiac Failure |
15.9% |
| Prophylaxis |
8.9% |
| Hypertension |
7.5% |
| Chronic Hepatitis C |
7.1% |
| Pulmonary Arterial Hypertension |
4.5% |
| Atrial Fibrillation |
4.0% |
| Hepatic Cirrhosis |
4.0% |
| Drug Use For Unknown Indication |
3.8% |
| Pulmonary Hypertension |
3.0% |
| Hepatitis C |
2.8% |
| Diabetes Mellitus |
2.7% |
| Hepatocellular Carcinoma |
2.7% |
| Cardiac Failure Chronic |
2.5% |
| Oedema |
2.3% |
| Immune Thrombocytopenic Purpura |
2.2% |
| Fluid Retention |
2.0% |
| Rheumatoid Arthritis |
1.9% |
| Insomnia |
1.8% |
| Gastrooesophageal Reflux Disease |
1.7% |
|
| Renal Impairment |
11.7% |
| White Blood Cell Count Decreased |
9.3% |
| Platelet Count Decreased |
6.8% |
| Pneumonia |
6.2% |
| Rash |
6.2% |
| Thirst |
5.6% |
| Renal Failure Acute |
4.9% |
| Urinary Tract Infection |
4.9% |
| Pancytopenia |
4.3% |
| Renal Disorder |
4.3% |
| Trisomy 13 |
4.3% |
| Vomiting |
4.3% |
| Hypernatraemia |
3.7% |
| Oedema Peripheral |
3.7% |
| Pyrexia |
3.7% |
| White Blood Cell Count Increased |
3.7% |
| Blood Urea Increased |
3.1% |
| Cerebral Infarction |
3.1% |
| Drug Eruption |
3.1% |
| Interstitial Lung Disease |
3.1% |
|
